Search Results 981-990 of 19943 for Receptor
Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery – a Qualitative Study Obesity ...
... receptors and nucleotide-binding-oligomerisation-domains (NOD), NOD-like receptors and their mutual interaction on epithelial cells and antigen-presenting cells ...
One primary objective is to compare the efficacy of 3 different endocrine therapies, the estrogen receptor ... receptor positive and HER2 negative breast cancer.
Previous treatment with glucagon-like peptide-1 receptor (GLP-1R) agonists within 3 months before screening. 2. Type 1 diabetes. 3. Less than 3 months ...
A phase III study of pafolacianine injection for intraoperative imaging of folate receptor — Positive ovarian cancer (study 006). Journal of Clinical ...
Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma. J Nucl Med. 2026 Jan ...
Efgartigimod alfa-fcab injection is used to treat a nerve and muscle problem called myasthenia gravis in patients who are anti-acetylcholine receptor (AChR) ...
... receptor (EGFR) gene (exon 19 deletions or exon 21 L858R substitution mutations). Your doctor will perform a test before you take this medicine. This ...
Background heart failure therapy that includes angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), and beta blockers ...
... receptor antagonist in adults with a clinical diagnosis of rheumatoid arthritis. Participation eligibility. Participant eligibility includes age, gender ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.